|
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical research trials and Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer. Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer  Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
For Condition: Leukemia,Lymphoma,Head and Neck Cancer,Lung Cancer,Eye Cancer,Gastrointestinal Cancer,Oral Cancer,Reproductive Cancer
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Eastern Cooperative Oncology Group
Synopsis: RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.
Details: OBJECTIVES: I. Compare the efficacy of brief physician-initiated smoking cessation strategies vs usual care in patients with early stage cancer who are undergoing treatment in clinical oncology settings. II. Compare the sociodemographic, smoking history, and health status correlates of smoking cessation in patients treated with these regimens. III. Determine the feasibility of conducting a cancer prevention and control study in a cooperative group setting by monitoring adherence to the smoking-cessation strategies. PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are stratified according to center. Patients are randomized to 1 of 2 treatment arms. Arm I: Patients receive usual care (no special intervention). Arm II: Patients receive smoking-cessation therapy based on the 4-step intervention plan in the "Manual for Physicians" published by the National Cancer Institute. The smoking cessation coordinator and physician provide self-quitting advice and support to the patient via counseling, self-help materials, and referral to a smoking cessation counselor at the Cancer Information Service (CIS). Patients receive nicotine replacement, if indicated. Patients who express an interest in more intensive treatment are referred to local American Cancer Society or American Lung Association clinics and/or advised to call the CIS for additional local program referrals. All patients are followed at 6 and 12 months. Patients who report that they are still smoking and interested in help to quit smoking at the 12-month follow-up interview are encouraged to return to their physicians and contact the CIS for additional help quitting or for a referral to more intensive or specialized treatments in their area. PROJECTED ACCRUAL: A total of 494 patients will be accrued for this study.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training
Minimum Age/Maximum Age: 19 Years/
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Diagnosis of stage I or II bladder, colorectal, head and neck, lung, or other cancer OR Diagnosis of stage I-III testicular cancer OR Diagnosis of stage I-IV breast cancer, prostate cancer, or lymphoma Must have smoked 1 or more cigarettes within the past month or define self as a smoker Hormone receptor status: Not specified --Prior/Concurrent Therapy-- Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not specified Other: No prior participation in the pilot phase study --Patient Characteristics-- Age: 19 and over Sex: Not specified Menopausal status: Not specified Performance status: ECOG 0-1 Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Cardiovascular: No history of recent heart attack Other: - Not pregnant - No other imminent medical needs requiring referral to a more intensive smoking cessation regimen
Total Enrollment:
Location and Contact Information:
Overall Study Official:
PaulEngstrom, Study Chair, Eastern Cooperative Oncology Group
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
United States
Additional Information:
Study ID Numbers: CDR0000078281; E-1Y92,NCI-P93-0042
Study Start Date: June 1992
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002520
Other Gastrointestinal Cancer Studies:
1. Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
2. Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
3. Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
4. Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
5. Genetic Study of Patients and Families With a History of Colorectal Cancer
Related Studies:
Other Gastrointestinal Cancer Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
|
|
|
|
|
|
|
|
